|
Market Closed -
OTC Markets
12:06:02 2025-12-26 EST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 14-06-03 | Terme Bancorp Establishes Terme Medical Ventures, Inc. as its Subsidiary to Invest in Medical Initiatives | CI |
| Market Cap | 1.99M 1.75M 1.66M 1.5M 2.82M 191M 2.86M 19.84M 7.63M 97.4M 7.46M 7.3M 312M | P/E 2003 |
-0.4x | P/E 2004 | -0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 25.68M 22.61M 21.42M 19.34M 36.45M 2.46B 36.92M 256M 98.63M 1.26B 96.41M 94.31M 4.03B | EV / Sales 2003 |
16.4x | EV / Sales 2004 | -6.26x |
| Free-Float |
-
| Yield 2003 * |
-
| Yield 2004 | - |
| 22-05-01 | Terme Bancorp : Officer/Director Disclosure | PU |
| 22-03-31 | Terme Bancorp : Earnings Per Share 12/31/21 | PU |
| 22-03-31 | Terme Bancorp : Financial Foot Notes 12/31/21 | PU |
| 22-03-31 | Terme Bancorp : Income Statement 12/31/21 | PU |
| 22-03-31 | Terme Bancorp : Changes in Stockholder Equity 12/31/21 | PU |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.1 |
| 10 years | 0 | | 0.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
John G. Yedinak
CEO | Chief Executive Officer | 76 | - |
| 2003 | 2004 | |
|---|---|---|
| Net sales | 2.61M 2.3M 2.18M 1.97M 3.7M 250M 3.75M 26.04M 10.02M 128M 9.8M 9.58M 410M | -4.14M -3.65M -3.46M -3.12M -5.88M -397M -5.96M -41.38M -15.92M -203M -15.56M -15.22M -651M |
| Net income | -18.22M -16.04M -15.2M -13.72M -25.86M -1.75B -26.2M -182M -69.98M -893M -68.41M -66.92M -2.86B | -11.72M -10.32M -9.77M -8.82M -16.63M -1.12B -16.85M -117M -45M -574M -43.99M -43.03M -1.84B |
| Net Debt | 35.49M 31.26M 29.61M 26.73M 50.39M 3.4B 51.04M 354M 136M 1.74B 133M 130M 5.58B | 23.69M 20.86M 19.76M 17.84M 33.63M 2.27B 34.06M 236M 91M 1.16B 88.95M 87.01M 3.72B |
Employees
-
Sector
-
- Stock Market
- Stocks
- TMEB Stock
Select your edition
All financial news and data tailored to specific country editions
